|Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up|
H Tilly, MG Da Silva, U Vitolo, A Jack, M Meignan, A Lopez-Guillermo, ...
Annals of oncology 26, v116-v125, 2015
|MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis|
F Pichiorri, SS Suh, M Ladetto, M Kuehl, T Palumbo, D Drandi, C Taccioli, ...
Proceedings of the National Academy of Sciences 105 (35), 12885-12890, 2008
|Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up|
DA Eichenauer, BMP Aleman, M André, M Federico, M Hutchings, ...
Annals of Oncology 29, iv19-iv29, 2018
|Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study|
F Passamonti, C Cattaneo, L Arcaini, R Bruna, M Cavo, F Merli, ...
The Lancet Haematology 7 (10), e737-e745, 2020
|Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†☆|
M Dreyling, M Ghielmini, S Rule, G Salles, M Ladetto, SH Tonino, ...
Annals of Oncology 32 (3), 298-308, 2021
|ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma|
M Dreyling, C Thieblemont, A Gallamini, L Arcaini, E Campo, O Hermine, ...
Annals of Oncology 24 (4), 857-877, 2013
|Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders|
M Ladetto, M Brüggemann, L Monitillo, S Ferrero, F Pepin, D Drandi, ...
Leukemia 28 (6), 1299-1307, 2014
|Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma|
M Ladetto, G Pagliano, S Ferrero, F Cavallo, D Drandi, L Santo, C Crippa, ...
Journal of Clinical Oncology 28 (12), 2077-2084, 2010
|Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up|
M Dreyling, E Campo, O Hermine, M Jerkeman, S Le Gouill, S Rule, ...
Annals of Oncology 28, iv62-iv71, 2017
|Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells|
P Corradini, C Voena, C Tarella, M Astolfi, M Ladetto, A Palumbo, ...
Journal of Clinical Oncology 17 (1), 208-208, 1999
|Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis …|
M Ladetto, F De Marco, F Benedetti, U Vitolo, C Patti, A Rambaldi, ...
Blood, The Journal of the American Society of Hematology 111 (8), 4004-4013, 2008
|Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP|
P Pregno, A Chiappella, M Bellò, B Botto, S Ferrero, S Franceschetti, ...
Blood, The Journal of the American Society of Hematology 119 (9), 2066-2073, 2012
|Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up|
DA Eichenauer, A Engert, M André, M Federico, T Illidge, M Hutchings, ...
Annals of oncology 25, iii70-iii75, 2014
|Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome|
E Chigrinova, A Rinaldi, I Kwee, D Rossi, PMV Rancoita, JC Strefford, ...
Blood, The Journal of the American Society of Hematology 122 (15), 2673-2682, 2013
|Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up|
E Zucca, C Copie-Bergman, U Ricardi, C Thieblemont, M Raderer, ...
Annals of Oncology 24, vi144-vi148, 2013
|Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome|
D Rossi, V Spina, M Cerri, S Rasi, C Deambrogi, L De Paoli, L Laurenti, ...
Clinical Cancer Research 15 (13), 4415-4422, 2009
|ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)|
M Ghielmini, U Vitolo, E Kimby, S Montoto, J Walewski, M Pfreundschuh, ...
Annals of oncology 24 (3), 561-576, 2013
|Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies|
A Trojan, JL Schultze, M Witzens, RH Vonderheide, M Ladetto, ...
Nature medicine 6 (6), 667-672, 2000
|Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up✰|
E Zucca, L Arcaini, C Buske, PW Johnson, M Ponzoni, M Raderer, ...
Annals of oncology 31 (1), 17-29, 2020
|Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell …|
P Corradini, M Astolfi, C Cherasco, M Ladetto, C Voena, D Caracciolo, ...
Blood, The Journal of the American Society of Hematology 89 (2), 724-491, 1997